What is the projected market valuation of the Intravenous Solution Market by 2035?

The Intravenous Solution Market is projected to reach a valuation of 33.92 USD Billion by 2035. Read More

What was the market valuation of the Intravenous Solution Market in 2024?

In 2024, the market valuation of the Intravenous Solution Market was 14.97 USD Billion. Read More

What is the expected CAGR for the Intravenous Solution Market during the forecast period 2025 - 2035?

The expected CAGR for the Intravenous Solution Market during the forecast period 2025 - 2035 is 7.72%. Read More

Which companies are considered key players in the Intravenous Solution Market?

Key players in the Intravenous Solution Market include Baxter International Inc, B. Braun Melsungen AG, and Fresenius Kabi AG. Read More

What are the projected revenues for Peripheral Parenteral Nutrition by 2035?

The projected revenue for Peripheral Parenteral Nutrition is expected to reach 13.36 USD Billion by 2035. Read More

How do the revenues of Large Volume Bags compare to Small Volume Bags by 2035?

By 2035, revenues for Large Volume Bags are projected to be 20.0 USD Billion, while Small Volume Bags are expected to reach 13.92 USD Billion. Read More

What is the anticipated market size for Home Care as an end user by 2035?

The anticipated market size for Home Care as an end user is projected to be 13.42 USD Billion by 2035. Read More

What are the expected revenues for Amino Acid Solutions by 2035?

Amino Acid Solutions are expected to generate revenues of 6.73 USD Billion by 2035. Read More

What segment of nutritional content is projected to have the highest revenue by 2035?

Carbohydrates are projected to have the highest revenue among nutritional content segments, reaching 7.48 USD Billion by 2035. Read More

What is the projected revenue for the Total Parenteral Nutrition segment by 2035?

The Total Parenteral Nutrition segment is projected to reach revenues of 20.56 USD Billion by 2035. Read More

Intravenous Solution Market

ID: MRFR/HC/0727-CR

124 Pages

Nidhi Mandole

Last Updated: May 15, 2026

Intravenous solution market Research Report Information By Nutrition Type (Peripheral Parenteral Nutrition and Total Parenteral Nutrition), By Bag Type (Large Volume Bags (>250 ml) and Small Volume Bags (<250 ml)), By Nutritional Content (Amino Acid Solution, Carbohydrates, Vitamins & Minerals, Parenteral Lipid Emulsion, and Others), By End User (Hospital & Clinics, Ambulatory Surgical Centers, and Home Care), And By Region (North America, Europe, Asia-Pacific, And Rest Of The World) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Methodology Download PDF

Certified Researchers

Customize Report

SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS |
1. 1.1 EXECUTIVE SUMMARY | |
  1. 1.1.1 Market Overview | |
  2. 1.1.2 Key Findings | |
  3. 1.1.3 Market Segmentation | |
  4. 1.1.4 Competitive Landscape | |
  5. 1.1.5 Challenges and Opportunities | |
  6. 1.1.6 Future Outlook 2
SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE |
1. 2.1 MARKET INTRODUCTION | |
  1. 2.1.1 Definition | |
  2. 2.1.2 Scope of the study | | |
    1. 2.1.2.1 Research Objective | | |
    2. 2.1.2.2 Assumption | | |
    3. 2.1.2.3 Limitations |
2. 2.2 RESEARCH METHODOLOGY | |
  1. 2.2.1 Overview | |
  2. 2.2.2 Data Mining | |
  3. 2.2.3 Secondary Research | |
  4. 2.2.4 Primary Research | | |
    1. 2.2.4.1 Primary Interviews and Information Gathering Process | | |
    2. 2.2.4.2 Breakdown of Primary Respondents | |
  5. 2.2.5 Forecasting Model | |
  6. 2.2.6 Market Size Estimation | | |
    1. 2.2.6.1 Bottom-Up Approach | | |
    2. 2.2.6.2 Top-Down Approach | |
  7. 2.2.7 Data Triangulation | |
  8. 2.2.8 Validation 3
SECTION III: QUALITATIVE ANALYSIS |
1. 3.1 MARKET DYNAMICS | |
  1. 3.1.1 Overview | |
  2. 3.1.2 Drivers | |
  3. 3.1.3 Restraints | |
  4. 3.1.4 Opportunities |
2. 3.2 MARKET FACTOR ANALYSIS | |
  1. 3.2.1 Value chain Analysis | |
  2. 3.2.2 Porter's Five Forces Analysis | | |
    1. 3.2.2.1 Bargaining Power of Suppliers | | |
    2. 3.2.2.2 Bargaining Power of Buyers | | |
    3. 3.2.2.3 Threat of New Entrants | | |
    4. 3.2.2.4 Threat of Substitutes | | |
    5. 3.2.2.5 Intensity of Rivalry | |
  3. 3.2.3 COVID-19 Impact Analysis | | |
    1. 3.2.3.1 Market Impact Analysis | | |
    2. 3.2.3.2 Regional Impact | | |
    3. 3.2.3.3 Opportunity and Threat Analysis 4
SECTION IV: QUANTITATIVE ANALYSIS |
1. 4.1 Healthcare, BY Nutrition Type (USD Billion) | |
  1. 4.1.1 Peripheral Parenteral Nutrition | |
  2. 4.1.2 Total Parenteral Nutrition |
2. 4.2 Healthcare, BY Bag Type (USD Billion) | |
  1. 4.2.1 Large Volume Bags (>250 ml) | |
  2. 4.2.2 Small Volume Bags (<250 ml) |
3. 4.3 Healthcare, BY End User (USD Billion) | |
  1. 4.3.1 Hospital & Clinics | |
  2. 4.3.2 Ambulatory Surgical Centers | |
  3. 4.3.3 Home Care |
4. 4.4 Healthcare, BY Nutritional Content (USD Billion) | |
  1. 4.4.1 Amino Acid Solution | |
  2. 4.4.2 Carbohydrates | |
  3. 4.4.3 Vitamins & Minerals | |
  4. 4.4.4 Parenteral Lipid Emulsion | |
  5. 4.4.5 Others |
5. 4.5 Healthcare, BY Region (USD Billion) | |
  1. 4.5.1 North America | | |
    1. 4.5.1.1 US | | |
    2. 4.5.1.2 Canada | |
  2. 4.5.2 Europe | | |
    1. 4.5.2.1 Germany | | |
    2. 4.5.2.2 UK | | |
    3. 4.5.2.3 France | | |
    4. 4.5.2.4 Russia | | |
    5. 4.5.2.5 Italy | | |
    6. 4.5.2.6 Spain | | |
    7. 4.5.2.7 Rest of Europe | |
  3. 4.5.3 APAC | | |
    1. 4.5.3.1 China | | |
    2. 4.5.3.2 India | | |
    3. 4.5.3.3 Japan | | |
    4. 4.5.3.4 South Korea | | |
    5. 4.5.3.5 Malaysia | | |
    6. 4.5.3.6 Thailand | | |
    7. 4.5.3.7 Indonesia | | |
    8. 4.5.3.8 Rest of APAC | |
  4. 4.5.4 South America | | |
    1. 4.5.4.1 Brazil | | |
    2. 4.5.4.2 Mexico | | |
    3. 4.5.4.3 Argentina | | |
    4. 4.5.4.4 Rest of South America | |
  5. 4.5.5 MEA | | |
    1. 4.5.5.1 GCC Countries | | |
    2. 4.5.5.2 South Africa | | |
    3. 4.5.5.3 Rest of MEA 5
SECTION V: COMPETITIVE ANALYSIS |
1. 5.1 Competitive Landscape | |
  1. 5.1.1 Overview | |
  2. 5.1.2 Competitive Analysis | |
  3. 5.1.3 Market share Analysis | |
  4. 5.1.4 Major Growth Strategy in the Healthcare | |
  5. 5.1.5 Competitive Benchmarking | |
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare | |
  7. 5.1.7 Key developments and growth strategies | | |
    1. 5.1.7.1 New Product Launch/Service Deployment | | |
    2. 5.1.7.2 Merger & Acquisitions | | |
    3. 5.1.7.3 Joint Ventures | |
  8. 5.1.8 Major Players Financial Matrix | | |
    1. 5.1.8.1 Sales and Operating Income | | |
    2. 5.1.8.2 Major Players R&D Expenditure. 2023 |
2. 5.2 Company Profiles | |
  1. 5.2.1 Baxter International Inc (US) | | |
    1. 5.2.1.1 Financial Overview | | |
    2. 5.2.1.2 Products Offered | | |
    3. 5.2.1.3 Key Developments | | |
    4. 5.2.1.4 SWOT Analysis | | |
    5. 5.2.1.5 Key Strategies | |
  2. 5.2.2 B. Braun Melsungen AG (DE) | | |
    1. 5.2.2.1 Financial Overview | | |
    2. 5.2.2.2 Products Offered | | |
    3. 5.2.2.3 Key Developments | | |
    4. 5.2.2.4 SWOT Analysis | | |
    5. 5.2.2.5 Key Strategies | |
  3. 5.2.3 Fresenius Kabi AG (DE) | | |
    1. 5.2.3.1 Financial Overview | | |
    2. 5.2.3.2 Products Offered | | |
    3. 5.2.3.3 Key Developments | | |
    4. 5.2.3.4 SWOT Analysis | | |
    5. 5.2.3.5 Key Strategies | |
  4. 5.2.4 Hospira Inc (US) | | |
    1. 5.2.4.1 Financial Overview | | |
    2. 5.2.4.2 Products Offered | | |
    3. 5.2.4.3 Key Developments | | |
    4. 5.2.4.4 SWOT Analysis | | |
    5. 5.2.4.5 Key Strategies | |
  5. 5.2.5 Terumo Corporation (JP) | | |
    1. 5.2.5.1 Financial Overview | | |
    2. 5.2.5.2 Products Offered | | |
    3. 5.2.5.3 Key Developments | | |
    4. 5.2.5.4 SWOT Analysis | | |
    5. 5.2.5.5 Key Strategies | |
  6. 5.2.6 Otsuka Pharmaceutical Co Ltd (JP) | | |
    1. 5.2.6.1 Financial Overview | | |
    2. 5.2.6.2 Products Offered | | |
    3. 5.2.6.3 Key Developments | | |
    4. 5.2.6.4 SWOT Analysis | | |
    5. 5.2.6.5 Key Strategies | |
  7. 5.2.7 Grifols S.A. (ES) | | |
    1. 5.2.7.1 Financial Overview | | |
    2. 5.2.7.2 Products Offered | | |
    3. 5.2.7.3 Key Developments | | |
    4. 5.2.7.4 SWOT Analysis | | |
    5. 5.2.7.5 Key Strategies | |
  8. 5.2.8 Eagle Pharmaceuticals Inc (US) | | |
    1. 5.2.8.1 Financial Overview | | |
    2. 5.2.8.2 Products Offered | | |
    3. 5.2.8.3 Key Developments | | |
    4. 5.2.8.4 SWOT Analysis | | |
    5. 5.2.8.5 Key Strategies |
3. 5.3 Appendix | |
  1. 5.3.1 References | |
  2. 5.3.2 Related Reports 6 LIST OF FIGURES |
4. 6.1 MARKET SYNOPSIS |
5. 6.2 NORTH AMERICA MARKET ANALYSIS |
6. 6.3 US MARKET ANALYSIS BY NUTRITION TYPE |
7. 6.4 US MARKET ANALYSIS BY BAG TYPE |
8. 6.5 US MARKET ANALYSIS BY END USER |
9. 6.6 US MARKET ANALYSIS BY NUTRITIONAL CONTENT |
10. 6.7 CANADA MARKET ANALYSIS BY NUTRITION TYPE |
11. 6.8 CANADA MARKET ANALYSIS BY BAG TYPE |
12. 6.9 CANADA MARKET ANALYSIS BY END USER |
13. 6.10 CANADA MARKET ANALYSIS BY NUTRITIONAL CONTENT |
14. 6.11 EUROPE MARKET ANALYSIS |
15. 6.12 GERMANY MARKET ANALYSIS BY NUTRITION TYPE |
16. 6.13 GERMANY MARKET ANALYSIS BY BAG TYPE |
17. 6.14 GERMANY MARKET ANALYSIS BY END USER |
18. 6.15 GERMANY MARKET ANALYSIS BY NUTRITIONAL CONTENT |
19. 6.16 UK MARKET ANALYSIS BY NUTRITION TYPE |
20. 6.17 UK MARKET ANALYSIS BY BAG TYPE |
21. 6.18 UK MARKET ANALYSIS BY END USER |
22. 6.19 UK MARKET ANALYSIS BY NUTRITIONAL CONTENT |
23. 6.20 FRANCE MARKET ANALYSIS BY NUTRITION TYPE |
24. 6.21 FRANCE MARKET ANALYSIS BY BAG TYPE |
25. 6.22 FRANCE MARKET ANALYSIS BY END USER |
26. 6.23 FRANCE MARKET ANALYSIS BY NUTRITIONAL CONTENT |
27. 6.24 RUSSIA MARKET ANALYSIS BY NUTRITION TYPE |
28. 6.25 RUSSIA MARKET ANALYSIS BY BAG TYPE |
29. 6.26 RUSSIA MARKET ANALYSIS BY END USER |
30. 6.27 RUSSIA MARKET ANALYSIS BY NUTRITIONAL CONTENT |
31. 6.28 ITALY MARKET ANALYSIS BY NUTRITION TYPE |
32. 6.29 ITALY MARKET ANALYSIS BY BAG TYPE |
33. 6.30 ITALY MARKET ANALYSIS BY END USER |
34. 6.31 ITALY MARKET ANALYSIS BY NUTRITIONAL CONTENT |
35. 6.32 SPAIN MARKET ANALYSIS BY NUTRITION TYPE |
36. 6.33 SPAIN MARKET ANALYSIS BY BAG TYPE |
37. 6.34 SPAIN MARKET ANALYSIS BY END USER |
38. 6.35 SPAIN MARKET ANALYSIS BY NUTRITIONAL CONTENT |
39. 6.36 REST OF EUROPE MARKET ANALYSIS BY NUTRITION TYPE |
40. 6.37 REST OF EUROPE MARKET ANALYSIS BY BAG TYPE |
41. 6.38 REST OF EUROPE MARKET ANALYSIS BY END USER |
42. 6.39 REST OF EUROPE MARKET ANALYSIS BY NUTRITIONAL CONTENT |
43. 6.40 APAC MARKET ANALYSIS |
44. 6.41 CHINA MARKET ANALYSIS BY NUTRITION TYPE |
45. 6.42 CHINA MARKET ANALYSIS BY BAG TYPE |
46. 6.43 CHINA MARKET ANALYSIS BY END USER |
47. 6.44 CHINA MARKET ANALYSIS BY NUTRITIONAL CONTENT |
48. 6.45 INDIA MARKET ANALYSIS BY NUTRITION TYPE |
49. 6.46 INDIA MARKET ANALYSIS BY BAG TYPE |
50. 6.47 INDIA MARKET ANALYSIS BY END USER |
51. 6.48 INDIA MARKET ANALYSIS BY NUTRITIONAL CONTENT |
52. 6.49 JAPAN MARKET ANALYSIS BY NUTRITION TYPE |
53. 6.50 JAPAN MARKET ANALYSIS BY BAG TYPE |
54. 6.51 JAPAN MARKET ANALYSIS BY END USER |
55. 6.52 JAPAN MARKET ANALYSIS BY NUTRITIONAL CONTENT |
56. 6.53 SOUTH KOREA MARKET ANALYSIS BY NUTRITION TYPE |
57. 6.54 SOUTH KOREA MARKET ANALYSIS BY BAG TYPE |
58. 6.55 SOUTH KOREA MARKET ANALYSIS BY END USER |
59. 6.56 SOUTH KOREA MARKET ANALYSIS BY NUTRITIONAL CONTENT |
60. 6.57 MALAYSIA MARKET ANALYSIS BY NUTRITION TYPE |
61. 6.58 MALAYSIA MARKET ANALYSIS BY BAG TYPE |
62. 6.59 MALAYSIA MARKET ANALYSIS BY END USER |
63. 6.60 MALAYSIA MARKET ANALYSIS BY NUTRITIONAL CONTENT |
64. 6.61 THAILAND MARKET ANALYSIS BY NUTRITION TYPE |
65. 6.62 THAILAND MARKET ANALYSIS BY BAG TYPE |
66. 6.63 THAILAND MARKET ANALYSIS BY END USER |
67. 6.64 THAILAND MARKET ANALYSIS BY NUTRITIONAL CONTENT |
68. 6.65 INDONESIA MARKET ANALYSIS BY NUTRITION TYPE |
69. 6.66 INDONESIA MARKET ANALYSIS BY BAG TYPE |
70. 6.67 INDONESIA MARKET ANALYSIS BY END USER |
71. 6.68 INDONESIA MARKET ANALYSIS BY NUTRITIONAL CONTENT |
72. 6.69 REST OF APAC MARKET ANALYSIS BY NUTRITION TYPE |
73. 6.70 REST OF APAC MARKET ANALYSIS BY BAG TYPE |
74. 6.71 REST OF APAC MARKET ANALYSIS BY END USER |
75. 6.72 REST OF APAC MARKET ANALYSIS BY NUTRITIONAL CONTENT |
76. 6.73 SOUTH AMERICA MARKET ANALYSIS |
77. 6.74 BRAZIL MARKET ANALYSIS BY NUTRITION TYPE |
78. 6.75 BRAZIL MARKET ANALYSIS BY BAG TYPE |
79. 6.76 BRAZIL MARKET ANALYSIS BY END USER |
80. 6.77 BRAZIL MARKET ANALYSIS BY NUTRITIONAL CONTENT |
81. 6.78 MEXICO MARKET ANALYSIS BY NUTRITION TYPE |
82. 6.79 MEXICO MARKET ANALYSIS BY BAG TYPE |
83. 6.80 MEXICO MARKET ANALYSIS BY END USER |
84. 6.81 MEXICO MARKET ANALYSIS BY NUTRITIONAL CONTENT |
85. 6.82 ARGENTINA MARKET ANALYSIS BY NUTRITION TYPE |
86. 6.83 ARGENTINA MARKET ANALYSIS BY BAG TYPE |
87. 6.84 ARGENTINA MARKET ANALYSIS BY END USER |
88. 6.85 ARGENTINA MARKET ANALYSIS BY NUTRITIONAL CONTENT |
89. 6.86 REST OF SOUTH AMERICA MARKET ANALYSIS BY NUTRITION TYPE |
90. 6.87 REST OF SOUTH AMERICA MARKET ANALYSIS BY BAG TYPE |
91. 6.88 REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER |
92. 6.89 REST OF SOUTH AMERICA MARKET ANALYSIS BY NUTRITIONAL CONTENT |
93. 6.90 MEA MARKET ANALYSIS |
94. 6.91 GCC COUNTRIES MARKET ANALYSIS BY NUTRITION TYPE |
95. 6.92 GCC COUNTRIES MARKET ANALYSIS BY BAG TYPE |
96. 6.93 GCC COUNTRIES MARKET ANALYSIS BY END USER |
97. 6.94 GCC COUNTRIES MARKET ANALYSIS BY NUTRITIONAL CONTENT |
98. 6.95 SOUTH AFRICA MARKET ANALYSIS BY NUTRITION TYPE |
99. 6.96 SOUTH AFRICA MARKET ANALYSIS BY BAG TYPE |
100. 6.97 SOUTH AFRICA MARKET ANALYSIS BY END USER |
101. 6.98 SOUTH AFRICA MARKET ANALYSIS BY NUTRITIONAL CONTENT |
102. 6.99 REST OF MEA MARKET ANALYSIS BY NUTRITION TYPE |
103. 6.100 REST OF MEA MARKET ANALYSIS BY BAG TYPE |
104. 6.101 REST OF MEA MARKET ANALYSIS BY END USER |
105. 6.102 REST OF MEA MARKET ANALYSIS BY NUTRITIONAL CONTENT |
106. 6.103 KEY BUYING CRITERIA OF HEALTHCARE |
107. 6.104 RESEARCH PROCESS OF MRFR |
108. 6.105 DRO ANALYSIS OF HEALTHCARE |
109. 6.106 DRIVERS IMPACT ANALYSIS: HEALTHCARE |
110. 6.107 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE |
111. 6.108 SUPPLY / VALUE CHAIN: HEALTHCARE |
112. 6.109 HEALTHCARE, BY NUTRITION TYPE, 2024 (% SHARE) |
113. 6.110 HEALTHCARE, BY NUTRITION TYPE, 2024 TO 2035 (USD Billion) |
114. 6.111 HEALTHCARE, BY BAG TYPE, 2024 (% SHARE) |
115. 6.112 HEALTHCARE, BY BAG TYPE, 2024 TO 2035 (USD Billion) |
116. 6.113 HEALTHCARE, BY END USER, 2024 (% SHARE) |
117. 6.114 HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion) |
118. 6.115 HEALTHCARE, BY NUTRITIONAL CONTENT, 2024 (% SHARE) |
119. 6.116 HEALTHCARE, BY NUTRITIONAL CONTENT, 2024 TO 2035 (USD Billion) |
120. 6.117 BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES |
121. 7.1 LIST OF ASSUMPTIONS | |
  1. 7.1.1 |
122. 7.2 North America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.2.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.2.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.2.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.2.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
123. 7.3 US MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.3.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.3.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.3.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.3.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
124. 7.4 Canada MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.4.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.4.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.4.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.4.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
125. 7.5 Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.5.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.5.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.5.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.5.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
126. 7.6 Germany MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.6.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.6.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.6.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.6.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
127. 7.7 UK MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.7.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.7.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.7.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.7.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
128. 7.8 France MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.8.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.8.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.8.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.8.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
129. 7.9 Russia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.9.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.9.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.9.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.9.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
130. 7.10 Italy MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.10.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.10.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.10.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.10.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
131. 7.11 Spain MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.11.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.11.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.11.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.11.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
132. 7.12 Rest of Europe MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.12.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.12.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.12.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.12.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
133. 7.13 APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.13.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.13.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.13.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.13.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
134. 7.14 China MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.14.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.14.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.14.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.14.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
135. 7.15 India MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.15.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.15.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.15.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.15.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
136. 7.16 Japan MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.16.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.16.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.16.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.16.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
137. 7.17 South Korea MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.17.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.17.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.17.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.17.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
138. 7.18 Malaysia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.18.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.18.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.18.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.18.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
139. 7.19 Thailand MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.19.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.19.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.19.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.19.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
140. 7.20 Indonesia MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.20.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.20.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.20.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.20.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
141. 7.21 Rest of APAC MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.21.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.21.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.21.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.21.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
142. 7.22 South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.22.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.22.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.22.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.22.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
143. 7.23 Brazil MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.23.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.23.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.23.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.23.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
144. 7.24 Mexico MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.24.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.24.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.24.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.24.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
145. 7.25 Argentina MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.25.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.25.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.25.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.25.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
146. 7.26 Rest of South America MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.26.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.26.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.26.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.26.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
147. 7.27 MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.27.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.27.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.27.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.27.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
148. 7.28 GCC Countries MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.28.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.28.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.28.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.28.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
149. 7.29 South Africa MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.29.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.29.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.29.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.29.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
150. 7.30 Rest of MEA MARKET SIZE ESTIMATES; FORECAST | |
  1. 7.30.1 BY NUTRITION TYPE, 2025-2035 (USD Billion) | |
  2. 7.30.2 BY BAG TYPE, 2025-2035 (USD Billion) | |
  3. 7.30.3 BY END USER, 2025-2035 (USD Billion) | |
  4. 7.30.4 BY NUTRITIONAL CONTENT, 2025-2035 (USD Billion) |
151. 7.31 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL | |
  1. 7.31.1 |
152. 7.32 ACQUISITION/PARTNERSHIP | |

Certified Researchers

Customize Report

Intravenous Solution Market Segmentation

Intravenous Solution Market By Nutrition Type (USD Billion, 2025-2035)

Peripheral Parenteral Nutrition
Total Parenteral Nutrition

Intravenous Solution Market By Bag Type (USD Billion, 2025-2035)

Large Volume Bags (>250 ml)
Small Volume Bags (<250 ml)

Intravenous Solution Market By End User (USD Billion, 2025-2035)

Hospital & Clinics
Ambulatory Surgical Centers
Home Care

Intravenous Solution Market By Nutritional Content (USD Billion, 2025-2035)

Amino Acid Solution
Carbohydrates
Vitamins & Minerals
Parenteral Lipid Emulsion
Others

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”